Interleukin-10 (IL-10) gene polymorphism as a potential host susceptibility factor in tuberculosis

Cytokine

Volumn 35, Issue 3-4, 2006, Pages 143-147

  Oral, Haluk B ^a   Budak, Ferah ^a   Uzaslan, Esra Kunt ^a   Baştürk, Bilkay ^b   Bekar, Ahmet ^a   Akalin, Halis ^a   Ege, Ercüment ^a   Ener, Beyza ^a   Göral, Güher ^a  

^a ULUDAG UNIVERSITY   (Turkey)

^b GAZI UNIVERSITY   (Turkey)

Author keywords

Cytokine; Genotyping; PCR SSP; Tuberculosis

Indexed keywords

CYTOKINE; DNA; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 6; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HOST SUSCEPTIBILITY; HUMAN; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN FUNCTION; RISK ASSESSMENT; STATISTICAL SIGNIFICANCE; TUBERCULOSIS;

ALLELES; CASE-CONTROL STUDIES; CYTOKINES; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-6; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; TRANSFORMING GROWTH FACTOR BETA; TUBERCULOSIS; TURKEY;

EID: 33750510719     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2006.07.015     Document Type: Article

References (41)

1. Fatkenheuer G., Taelman H., Lepage P., Schwenk A., and Wenzel R. The return of tuberculosis. Diagn Microbiol Infect Dis 34 (1999) 139-146
2. Hill A.V. The genomics and genetics of human infectious disease susceptibility. Annu Rev Genomics Hum Genet 2 (2001) 373-400
3. Sher A., and Coffman R.L. Regulation of immunity to parasites by T cells and T cell-derived cytokines. Annu Rev Immunol 10 (1992) 385-409
4. Wallis R.S., and Ellner J.J. Cytokines and tuberculosis. J Leukoc Biol 55 (1994) 676-681
5. Turner J., Gonzalez-Juarrero M., Ellis D.L., et al. In vivo IL-10 production reactivates chronic pulmonary tuberculosis in C57BL/6 mice. J Immunol 169 (2002) 6343-6351
6. Orme I.M. The immunopathogenesis of tuberculosis: a new working hypothesis. Trends Microbiol 6 (1998) 94-97
7. Bidwell J., Keen L., Gallagher G., et al. Cytokine gene polymorphism in human disease: on-line databases. Genes Immun 1 (1999) 3-19
8. Bidwell J., Keen L., Gallagher G., et al. Cytokine gene polymorphism in human disease: on-line databases, supplement 1. Genes Immun 2 (2001) 61-70
9. Hill A.V. The immunogenetics of human infectious diseases. Annu Rev Immunol 16 (1998) 593-617
10. Haukim N., Bidwell J.L., Smith A.J., et al. Cytokine gene polymorphism in human disease: on-line databases, supplement 2. Genes Immun 3 (2002) 313-330
11. Gesser B., Leffers H., Jinquan T., et al. Identification of functional domains on human interleukin 10. Proc Natl Acad Sci USA 94 (1997) 14620-14625
12. Moore K.W., de Waal Malefyt R., Coffman R.L., and O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 19 (2001) 683-765
13. de Waal Malefyt R., Abrams J., Bennett B., Figdor C.G., and de Vries J.E. Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 174 (1991) 1209-1220
14. de Waal Malefyt R., Haanen J., Spits H., et al. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J Exp Med 174 (1991) 915-924
15. Akdis C.A., Joss A., Akdis M., Faith A., and Blaser K. A molecular basis for T cell suppression by IL-10: CD28-associated IL-10 receptor inhibits CD28 tyrosine phosphorylation and phosphatidylinositol 3-kinase binding. FASEB J 14 (2000) 1666-1668
16. Cohen S.B., Crawley J.B., Kahan M.C., Feldmann M., and Foxwell B.M. Interleukin-10 rescues T cells from apoptotic cell death: association with an upregulation of Bcl-2. Immunology 92 (1997) 1-5
17. Redpath S., Ghazal P., and Gascoigne N.R. Hijacking and exploitation of IL-10 by intracellular pathogens. Trends Microbiol 9 (2001) 86-92
18. Fortsch D., Rollinghoff M., and Stenger S. IL-10 converts human dendritic cells into macrophage-like cells with increased antibacterial activity against virulent Mycobacterium tuberculosis. J Immunol 165 (2000) 978-987
19. Delgado J.C., Baena A., Thim S., and Goldfeld A.E. Ethnic-specific genetic associations with pulmonary tuberculosis. J Infect Dis 186 (2002) 1463-1468
20. Scola L., Crivello A., Marino V., et al. IL-10 and TNF-alpha polymorphisms in a sample of Sicilian patients affected by tuberculosis: implication for ageing and life span expectancy. Mech Ageing Dev 124 (2003) 569-572
21. Henao M.I., Montes C., Paris S.C., and Garcia L.F. Cytokine gene polymorphisms in Colombian patients with different clinical presentations of tuberculosis. Tuberculosis 86 (2006) 11-19
22. Lopez-Maderuelo D., Arnalich F., Serantes R., et al. Interferon-gamma and interleukin-10 gene polymorphisms in pulmonary tuberculosis. Am J Respir Crit Care Med 167 (2003) 970-975
23. Bellamy R., Ruwende C., Corrah T., McAdam K.P., Whittle H.C., and Hill A.V. Assessment of the interleukin 1 gene cluster and other candidate gene polymorphisms in host susceptibility to tuberculosis. Tuber Lung Dis 79 (1998) 83-89
24. Collins H.L., and Kaufmann S.H. The many faces of host responses to tuberculosis. Immunology 103 (2001) 1-9
25. Cooper A.M., Dalton D.K., Stewart T.A., Griffin J.P., Russell D.G., and Orme I.M. Disseminated tuberculosis in interferon gamma gene-disrupted mice. J Exp Med 178 (1993) 2243-2247
26. Jouanguy E., Altare F., Lamhamedi S., et al. Interferon-gamma-receptor deficiency in an infant with fatal bacille Calmette-Guerin infection. N Engl J Med 335 (1996) 1956-1961
27. Pravica V., Perrey C., Stevens A., Lee J.H., and Hutchinson I.V. A single nucleotide polymorphism in the first intron of the human IFN-gamma gene: absolute correlation with a polymorphic CA microsatellite marker of high IFN-gamma production. Hum Immunol 61 (2000) 863-866
28. Lio D., Marino V., Serauto A., et al. Genotype frequencies of the +874T→A single nucleotide polymorphism in the first intron of the interferon-gamma gene in a sample of Sicilian patients affected by tuberculosis. Eur J Immunogenet 29 (2002) 371-374
29. Garcia I., Miyazaki Y., Marchal G., Lesslauer W., and Vassalli P. High sensitivity of transgenic mice expressing soluble TNFR1 fusion protein to mycobacterial infections: synergistic action of TNF and IFN-gamma in the differentiation of protective granulomas. Eur J Immunol 27 (1997) 3182-3190
30. Bean A.G., Roach D.R., Briscoe H., et al. Structural deficiencies in granuloma formation in TNF gene-targeted mice underlie the heightened susceptibility to aerosol Mycobacterium tuberculosis infection, which is not compensated for by lymphotoxin. J Immunol 162 (1999) 3504-3511
31. Gomez-Reino J.J., Carmona L., Valverde V.R., Mola E.M., and Montero M.D. Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report. Arthritis Rheum 48 (2003) 2122-2127
32. Shaw M.A., Collins A., Peacock C.S., et al. Evidence that genetic susceptibility to Mycobacterium tuberculosis in a Brazilian population is under oligogenic control: linkage study of the candidate genes NRAMP1 and TNFA. Tuber Lung Dis 78 (1997) 35-45
33. Goldfeld A.E., Delgado J.C., Thim S., et al. Association of an HLA-DQ allele with clinical tuberculosis. JAMA 279 (1998) 226-228
34. Wahl S.M., McCartney-Francis N., and Mergenhagen S.E. Inflammatory and immunomodulatory roles of TGF-beta. Immunol Today 10 (1989) 258-261
35. Tsunawaki S., Sporn M., Ding A., and Nathan C. Deactivation of macrophages by transforming growth factor-beta. Nature 334 (1988) 260-262
36. Roberts A.B., Sporn M.B., Assoian R.K., et al. Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci USA 83 (1986) 4167-4171
37. Broekelmann T.J., Limper A.H., Colby T.V., and McDonald J.A. Transforming growth factor beta 1 is present at sites of extracellular matrix gene expression in human pulmonary fibrosis. Proc Natl Acad Sci USA 88 (1991) 6642-6646
38. Giacomini E., Iona E., Ferroni L., et al. Infection of human macrophages and dendritic cells with Mycobacterium tuberculosis induces a differential cytokine gene expression that modulates T cell response. J Immunol 166 (2001) 7033-7041
39. Indrigo J., Hunter Jr. R.L., and Actor J.K. Influence of trehalose 6,6′-dimycolate (TDM) during mycobacterial infection of bone marrow macrophages. Microbiology 148 (2002) 1991-1998
40. el-Ahmady O., Mansour M., Zoeir H., and Mansour O. Elevated concentrations of interleukins and leukotriene in response to Mycobacterium tuberculosis infection. Ann Clin Biochem 34 Pt 2 (1997) 160-164
41. Nagabhushanam V., Solache A., Ting L.M., Escaron C.J., Zhang J.Y., and Ernst J.D. Innate inhibition of adaptive immunity: Mycobacterium tuberculosis-induced IL-6 inhibits macrophage responses to IFN-gamma. J Immunol 171 (2003) 4750-4757